Status: Recruiting
New Assessment System in Measuring Symptom Distress in Cancer Patients
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
Participants needed: 6,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: M.D. Anderson Cancer CenterUpdated: Jan 21, 2026Locations: 1
Eligibility criteria
NORMAL SAMPLES: Community dwelling adults 18 years of age or older [+4]
EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver part...